Company Profile
NEXGEL Stock Price, News & Catalysts
- Ticker:
- NXGL
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.18 USD (+3.30%)
Close
Last updated: October 1, 2026
5.31M USD
Market cap
Why the stock is moving
As of Oct 1, 2026, NXGL closed up 3.30% at $0.1785. No new same-company headline was identified in the current news window.
Company overview
Hydrogel and Healthcare Products Company
NEXGEL develops, manufactures, and commercializes healthcare, beauty, and over-the-counter products. Its core expertise is in soft, high-water-content hydrogels used in wound care, skin care, consumer health, and other applications requiring gentle contact with the body.
Cross-Linked Hydrogel Platform
The company has more than two decades of experience manufacturing electron-beam cross-linked hydrogels. This process supports hydrogel products with customizable adhesion, moisture, cooling, and delivery characteristics for both proprietary brands and third-party customers.
Consumer and Wound-Care Brands
NEXGEL's branded portfolio includes SilverSeal, Hexagels, Turfguard, Kenkoderm, and Silly George. The products span wound dressings, blister and skin protection, dermatology, and beauty applications, allowing the company to address both professional healthcare channels and direct-to-consumer markets.
BioNX Surgical
BioNX Surgical expands NEXGEL into regenerative surgical products following the acquisition of assets from Celularity. The division is integrating sales relationships and transferring manufacturing capabilities with Sequence Life Science to support tissue-product availability and expansion into hospitals and ambulatory surgery centers.
Regenerative Eye Health and Aesthetics
BioNX Regenerative Eye Health & Aesthetics is a commercial initiative focused on ocular and aesthetic applications. It incorporates exclusively licensed products from Sequence and extends the company's regenerative-medicine strategy into physician-directed specialty markets.
Contract Manufacturing
Alongside its owned brands, NEXGEL manufactures hydrogel products for established consumer healthcare companies. This contract-manufacturing activity uses the same materials and production expertise that support its internal healthcare and consumer portfolio.
Future catalysts
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of NEXGEL (NXGL)?
NEXGEL (NXGL) most recently closed at 0.18 USD, a +3.30% move versus the previous session.
What is the market cap of NEXGEL (NXGL)?
NEXGEL currently has a market capitalization of 5.31M USD on BioPharmSignal.
What does NEXGEL do?
Hydrogel and Healthcare Products Company NEXGEL develops, manufactures, and commercializes healthcare, beauty, and over-the-counter products. Its core expertise is in soft, high-water-content hydrogels used in wound care, skin care, consumer health, and other applications requiring gentle contact with the body. Cross-Linked Hydrogel Platform The company has...
On which exchange is NXGL stock listed?
NEXGEL (NXGL) is associated with NASDAQ, United States, Biopharma.
What is Hydrogel?
Hydrogel and Healthcare Products Company NEXGEL develops, manufactures, and commercializes healthcare, beauty, and over-the-counter products.
Which conditions is NEXGEL targeting with Hydrogel?
NEXGEL is associated with dermatology based on its company overview and current catalyst commentary.
What is Healthcare?
Hydrogel and Healthcare Products Company NEXGEL develops, manufactures, and commercializes healthcare, beauty, and over-the-counter products.
What is Products?
Hydrogel and Healthcare Products Company NEXGEL develops, manufactures, and commercializes healthcare, beauty, and over-the-counter products.